Can GRACE risk score predict the in-hospital symtomatic heart failure development after myocardial infarction without ST segment elevation? GRACE risk skoru ST yükselmesiz miyokard infarktüsü sonrası semptomatik kalp yetersizliği gelişimini Öngörebilir mi?

Gül I., ŞENTÜRK B.

Turkiye Klinikleri Cardiovascular Sciences, cilt.32, sa.1, ss.1-8, 2020 (Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.5336/cardiosci.2019-70309
  • Dergi Adı: Turkiye Klinikleri Cardiovascular Sciences
  • Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1-8
  • Anahtar Kelimeler: Heart failure, Morbidity, Mortality, Myocardial infarction without ST segment elevation
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: The Global Registry of Acute Coronary Events (GRACE) risk score has a prognostic significance in patients with myocardial infarction without ST segment elevation (NSTEMI). In this study, we aimed to evaluate the significance of GRACE score at day 1 in predicting the development of in-hospital symptomatic heart failure (IH-HF) in patients presenting with NSTEMI. Material and Methods: Consecutive patients, admitted with NSTEMI between April 2016-May 2017 were evaluated in this prospective cohort study. A total of 179 patients (112 male, the mean age: 65.4±11.2) with left ventricular ejection fraction (LV-EF) <50% and N-terminal pro B-type natriuretic peptide (NT-proBNP) level >125pg/mL along with Killip Class 177.5 were found to be at higher risk for IH-HF development. Conclusion: The development of IH-HF in patients presenting with NSTEMI with asymptomatic left ventricular dysfunction significantly increases the morbidity and mortality rates. High GRACE score at day 1 in NSTEMI patients can be used to predict IH-HF.